{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:43:24Z","timestamp":1793054604195,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2010\/50015-6"],"award-info":[{"award-number":["2010\/50015-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2012\/03238-5"],"award-info":[{"award-number":["2012\/03238-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2014\/10198-5"],"award-info":[{"award-number":["2014\/10198-5"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2015\/10356-2"],"award-info":[{"award-number":["2015\/10356-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["304668\/2014-1"],"award-info":[{"award-number":["304668\/2014-1"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1154650"],"award-info":[{"award-number":["1154650"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Because the liver plays a major role in metabolic homeostasis and secretion of clotting factors and inflammatory innate immune proteins, there is interest in understanding the mechanisms of hepatic cell activation under hyperglycaemia and whether this can be attenuated pharmacologically. We have previously shown that hyperglycaemia stimulates major changes in chromatin organization and metabolism in hepatocytes, and that the histone deacetylase inhibitor valproic acid (VPA) is able to reverse some of these metabolic changes. In this study, we have used RNA-sequencing (RNA-seq) to investigate how VPA influences gene expression in hepatocytes. Interesting, we observed that VPA attenuates hyperglycaemia-induced activation of complement and coagulation cascade genes. We also observe that many of the gene activation events coincide with changes to histone acetylation at the promoter of these genes indicating that epigenetic regulation is involved in VPA action.<\/jats:p>","DOI":"10.1038\/s41598-021-81794-4","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T11:06:41Z","timestamp":1611572801000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Valproic acid influences the expression of genes implicated with hyperglycaemia-induced complement and coagulation pathways"],"prefix":"10.1038","volume":"11","author":[{"given":"Marina Barreto","family":"Felisbino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ziemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishant","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Al-Hasani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. N.","family":"Harikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camila Borges Martins","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luiza S.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assam","family":"El-Osta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,25]]},"reference":[{"key":"81794_CR1","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/dmrr.559","volume":"21","author":"SG Gray","year":"2005","unstructured":"Gray, S. G. & De Meyts, P. Role of histone and transcription factor acetylation in diabetes pathogenesis. Diabetes Metab. Res. Rev. 21, 416\u2013433. https:\/\/doi.org\/10.1002\/dmrr.559 (2005).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"81794_CR2","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1161\/circulationaha.107.720847","volume":"117","author":"TK Schramm","year":"2008","unstructured":"Schramm, T. K. et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: A population study of 3.3 million people. Circulation 117, 1945\u20131954. https:\/\/doi.org\/10.1161\/circulationaha.107.720847 (2008).","journal-title":"Circulation"},{"key":"81794_CR3","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.thromres.2011.11.052","volume":"129","author":"N Vazzana","year":"2012","unstructured":"Vazzana, N., Ranalli, P., Cuccurullo, C. & Dav\u00ec, G. Diabetes mellitus and thrombosis. Thromb. Res. 129, 371\u2013377. https:\/\/doi.org\/10.1016\/j.thromres.2011.11.052 (2012).","journal-title":"Thromb. Res."},{"key":"81794_CR4","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/j.1538-7836.2010.03910.x","volume":"8","author":"BA Lemkes","year":"2010","unstructured":"Lemkes, B. A. et al. Hyperglycemia: A prothrombotic factor?. J. Thromb. Haemost. 8, 1663\u20131669. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03910.x (2010).","journal-title":"J. Thromb. Haemost."},{"key":"81794_CR5","doi-asserted-by":"publisher","first-page":"e16470","DOI":"10.1371\/journal.pone.0016470","volume":"6","author":"Y Zhao","year":"2011","unstructured":"Zhao, Y., Zhang, J., Zhang, J. & Wu, J. Diabetes mellitus is associated with shortened activated partial thromboplastin time and increased fibrinogen values. PLoS ONE 6, e16470. https:\/\/doi.org\/10.1371\/journal.pone.0016470 (2011).","journal-title":"PLoS ONE"},{"key":"81794_CR6","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.smim.2013.04.003","volume":"25","author":"J Phieler","year":"2013","unstructured":"Phieler, J., Garcia-Martin, R., Lambris, J. D. & Chavakis, T. The role of the complement system in metabolic organs and metabolic diseases. Semin. Immunol. 25, 47\u201353. https:\/\/doi.org\/10.1016\/j.smim.2013.04.003 (2013).","journal-title":"Semin. Immunol."},{"issue":"Suppl 1","key":"81794_CR7","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1160\/ths10-11-0739","volume":"105","author":"K Hess","year":"2011","unstructured":"Hess, K. & Grant, P. J. Inflammation and thrombosis in diabetes. Thromb. Haemost. 105(Suppl 1), S43-54. https:\/\/doi.org\/10.1160\/ths10-11-0739 (2011).","journal-title":"Thromb. Haemost."},{"key":"81794_CR8","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/dmrr.2380","volume":"29","author":"T Fujita","year":"2013","unstructured":"Fujita, T. et al. Complement-mediated chronic inflammation is associated with diabetic microvascular complication. Diabetes Metab. Res. Rev. 29, 220\u2013226. https:\/\/doi.org\/10.1002\/dmrr.2380 (2013).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"81794_CR9","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1172\/jci110687","volume":"70","author":"KM Morris","year":"1982","unstructured":"Morris, K. M., Aden, D. P., Knowles, B. B. & Colten, H. R. Complement biosynthesis by the human hepatoma-derived cell line HepG2. J. Clin. Invest. 70, 906\u2013913. https:\/\/doi.org\/10.1172\/jci110687 (1982).","journal-title":"J. Clin. Invest."},{"key":"81794_CR10","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell, D. W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72, 137\u2013174. https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161712 (2003).","journal-title":"Annu. Rev. Biochem."},{"key":"81794_CR11","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nm.4146","volume":"22","author":"I Theurl","year":"2016","unstructured":"Theurl, I. et al. On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nat. Med. 22, 945\u2013951. https:\/\/doi.org\/10.1038\/nm.4146 (2016).","journal-title":"Nat. Med."},{"key":"81794_CR12","doi-asserted-by":"crossref","unstructured":"Sanchez, R. & Kauffman, F. Regulation of xenobiotic metabolism in the liver (2010).","DOI":"10.1016\/B978-0-08-046884-6.01005-8"},{"key":"81794_CR13","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2337\/diabetes.49.12.2063","volume":"49","author":"RS Hundal","year":"2000","unstructured":"Hundal, R. S. et al. Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes 49, 2063\u20132069. https:\/\/doi.org\/10.2337\/diabetes.49.12.2063 (2000).","journal-title":"Diabetes"},{"key":"81794_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cge.12121","volume":"84","author":"ST Keating","year":"2013","unstructured":"Keating, S. T. & El-Osta, A. Epigenetic changes in diabetes. Clin. Genet. 84, 1\u201310. https:\/\/doi.org\/10.1111\/cge.12121 (2013).","journal-title":"Clin. Genet."},{"key":"81794_CR15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12265-012-9380-9","volume":"5","author":"ST Keating","year":"2012","unstructured":"Keating, S. T. & El-Osta, A. Chromatin modifications associated with diabetes. J. Cardiovasc. Transl. Res. 5, 399\u2013412. https:\/\/doi.org\/10.1007\/s12265-012-9380-9 (2012).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"81794_CR16","doi-asserted-by":"publisher","first-page":"378","DOI":"10.2119\/molmed.2011.00021","volume":"17","author":"DP Christensen","year":"2011","unstructured":"Christensen, D. P. et al. Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus. Mol. Med. 17, 378\u2013390. https:\/\/doi.org\/10.2119\/molmed.2011.00021 (2011).","journal-title":"Mol. Med."},{"key":"81794_CR17","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/jcp.25343","volume":"231","author":"MB Felisbino","year":"2016","unstructured":"Felisbino, M. B., Alves da Costa, T., Gatti, M. S. & Mello, M. L. Differential response of human hepatocyte chromatin to HDAC inhibitors as a function of microenvironmental glucose level. J. Cell. Physiol. 231, 2257\u20132265. https:\/\/doi.org\/10.1002\/jcp.25343 (2016).","journal-title":"J. Cell. Physiol."},{"key":"81794_CR18","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.cell.2010.02.043","volume":"140","author":"CA Dinarello","year":"2010","unstructured":"Dinarello, C. A. Anti-inflammatory agents: Present and future. Cell 140, 935\u2013950. https:\/\/doi.org\/10.1016\/j.cell.2010.02.043 (2010).","journal-title":"Cell"},{"key":"81794_CR19","doi-asserted-by":"publisher","first-page":"8797206","DOI":"10.1155\/2016\/8797206","volume":"2016","author":"EE Hull","year":"2016","unstructured":"Hull, E. E., Montgomery, M. R. & Leyva, K. J. HDAC inhibitors as epigenetic regulators of the immune system: Impacts on cancer therapy and inflammatory diseases. Biomed. Res. Int. 2016, 8797206. https:\/\/doi.org\/10.1155\/2016\/8797206 (2016).","journal-title":"Biomed. Res. Int."},{"key":"81794_CR20","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.jacbts.2018.05.003","volume":"3","author":"MB Felisbino","year":"2018","unstructured":"Felisbino, M. B. & McKinsey, T. A. Epigenetics in cardiac fibrosis: Emphasis on Inflammation and fibroblast activation. JACC Basic Transl. Sci. 3, 704\u2013715. https:\/\/doi.org\/10.1016\/j.jacbts.2018.05.003 (2018).","journal-title":"JACC Basic Transl. Sci."},{"key":"81794_CR21","doi-asserted-by":"publisher","first-page":"9678098","DOI":"10.1155\/2019\/9678098","volume":"2019","author":"R Soria-Castro","year":"2019","unstructured":"Soria-Castro, R. et al. Exploring the drug repurposing versatility of valproic acid as a multifunctional regulator of innate and adaptive immune cells. J. Immunol. Res. 2019, 9678098. https:\/\/doi.org\/10.1155\/2019\/9678098 (2019).","journal-title":"J. Immunol. Res."},{"key":"81794_CR22","doi-asserted-by":"publisher","first-page":"e33453","DOI":"10.1371\/journal.pone.0033453","volume":"7","author":"J Halsall","year":"2012","unstructured":"Halsall, J., Gupta, V., O\u2019Neill, L. P., Turner, B. M. & Nightingale, K. P. Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors. PLoS ONE 7, e33453. https:\/\/doi.org\/10.1371\/journal.pone.0033453 (2012).","journal-title":"PLoS ONE"},{"key":"81794_CR23","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1101\/gr.168781.113","volume":"24","author":"H Rafehi","year":"2014","unstructured":"Rafehi, H. et al. Vascular histone deacetylation by pharmacological HDAC inhibition. Genome Res. 24, 1271\u20131284. https:\/\/doi.org\/10.1101\/gr.168781.113 (2014).","journal-title":"Genome Res."},{"key":"81794_CR24","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1080\/15592294.2015.1024406","volume":"10","author":"JY Ooi","year":"2015","unstructured":"Ooi, J. Y. et al. HDAC inhibition attenuates cardiac hypertrophy by acetylation and deacetylation of target genes. Epigenetics 10, 418\u2013430. https:\/\/doi.org\/10.1080\/15592294.2015.1024406 (2015).","journal-title":"Epigenetics"},{"key":"81794_CR25","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1080\/15592294.2017.1371892","volume":"12","author":"H Rafehi","year":"2017","unstructured":"Rafehi, H. et al. Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes. Epigenetics 12, 991\u20131003. https:\/\/doi.org\/10.1080\/15592294.2017.1371892 (2017).","journal-title":"Epigenetics"},{"key":"81794_CR26","first-page":"392","volume":"35","author":"MM Goldenberg","year":"2010","unstructured":"Goldenberg, M. M. Overview of drugs used for epilepsy and seizures: Etiology, diagnosis, and treatment. P t 35, 392\u2013415 (2010).","journal-title":"P t"},{"key":"81794_CR27","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.2174\/15680266113136660162","volume":"13","author":"BS Appleby","year":"2013","unstructured":"Appleby, B. S. & Cummings, J. L. Discovering new treatments for Alzheimer\u2019s disease by repurposing approved medications. Curr. Top. Med. Chem. 13, 2306\u20132327. https:\/\/doi.org\/10.2174\/15680266113136660162 (2013).","journal-title":"Curr. Top. Med. Chem."},{"key":"81794_CR28","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1002\/phar.2017","volume":"37","author":"DJ Gagnon","year":"2017","unstructured":"Gagnon, D. J., Fontaine, G. V., Riker, R. R. & Fraser, G. L. Repurposing valproate, enteral clonidine, and phenobarbital for comfort in adult ICU patients: A literature review with practical considerations. Pharmacotherapy 37, 1309\u20131321. https:\/\/doi.org\/10.1002\/phar.2017 (2017).","journal-title":"Pharmacotherapy"},{"key":"81794_CR29","doi-asserted-by":"publisher","first-page":"e0176855","DOI":"10.1371\/journal.pone.0176855","volume":"12","author":"CL Killick-Cole","year":"2017","unstructured":"Killick-Cole, C. L. et al. Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma. PLoS ONE 12, e0176855. https:\/\/doi.org\/10.1371\/journal.pone.0176855 (2017).","journal-title":"PLoS ONE"},{"key":"81794_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.113.089755","volume":"85","author":"LB Avery","year":"2014","unstructured":"Avery, L. B. & Bumpus, N. N. Valproic acid is a novel activator of AMP-activated protein kinase and decreases liver mass, hepatic fat accumulation, and serum glucose in obese mice. Mol. Pharmacol. 85, 1\u201310. https:\/\/doi.org\/10.1124\/mol.113.089755 (2014).","journal-title":"Mol. Pharmacol."},{"key":"81794_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.biochi.2014.12.015","volume":"110","author":"S Khan","year":"2015","unstructured":"Khan, S., Jena, G., Tikoo, K. & Kumar, V. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-\u03baB\/iNOS signaling in diabetic rat. Biochimie 110, 1\u201316. https:\/\/doi.org\/10.1016\/j.biochi.2014.12.015 (2015).","journal-title":"Biochimie"},{"key":"81794_CR32","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/dom.12470","volume":"17","author":"M Lundh","year":"2015","unstructured":"Lundh, M., Galbo, T., Poulsen, S. S. & Mandrup-Poulsen, T. Histone deacetylase 3 inhibition improves glycaemia and insulin secretion in obese diabetic rats. Diabetes Obes. Metab. 17, 703\u2013707. https:\/\/doi.org\/10.1111\/dom.12470 (2015).","journal-title":"Diabetes Obes. Metab."},{"key":"81794_CR33","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.bbrc.2010.11.086","volume":"404","author":"H Oiso","year":"2011","unstructured":"Oiso, H. et al. The role of class I histone deacetylase (HDAC) on gluconeogenesis in liver. Biochem. Biophys. Res. Commun. 404, 166\u2013172. https:\/\/doi.org\/10.1016\/j.bbrc.2010.11.086 (2011).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"81794_CR34","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cell.2011.03.043","volume":"145","author":"MM Mihaylova","year":"2011","unstructured":"Mihaylova, M. M. et al. Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis. Cell 145, 607\u2013621. https:\/\/doi.org\/10.1016\/j.cell.2011.03.043 (2011).","journal-title":"Cell"},{"key":"81794_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/qjmed\/hch007","volume":"97","author":"DK Kochar","year":"2004","unstructured":"Kochar, D. K. et al. Sodium valproate for painful diabetic neuropathy: A randomized double-blind placebo-controlled study. QJM 97, 33\u201338. https:\/\/doi.org\/10.1093\/qjmed\/hch007 (2004).","journal-title":"QJM"},{"key":"81794_CR36","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ejphar.2014.01.063","volume":"728","author":"BM Patel","year":"2014","unstructured":"Patel, B. M., Raghunathan, S. & Porwal, U. Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus. Eur. J. Pharmacol. 728, 128\u2013134. https:\/\/doi.org\/10.1016\/j.ejphar.2014.01.063 (2014).","journal-title":"Eur. J. Pharmacol."},{"key":"81794_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1152\/physiolgenomics.00001.2013","volume":"45","author":"F Miao","year":"2013","unstructured":"Miao, F. et al. RNA-sequencing analysis of high glucose-treated monocytes reveals novel transcriptome signatures and associated epigenetic profiles. Physiol. Genomics 45, 287\u2013299. https:\/\/doi.org\/10.1152\/physiolgenomics.00001.2013 (2013).","journal-title":"Physiol. Genomics"},{"key":"81794_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/genes10060406","author":"W Zhang","year":"2019","unstructured":"Zhang, W. et al. Transcriptome changes of skeletal muscle RNA-seq speculates the mechanism of postprandial hyperglycemia in diabetic Goto\u2013Kakizaki rats during the early stage of T2D. Genes (Basel) https:\/\/doi.org\/10.3390\/genes10060406 (2019).","journal-title":"Genes (Basel)"},{"key":"81794_CR39","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/nbt1342","volume":"25","author":"D Ricklin","year":"2007","unstructured":"Ricklin, D. & Lambris, J. D. Complement-targeted therapeutics. Nat. Biotechnol. 25, 1265\u20131275. https:\/\/doi.org\/10.1038\/nbt1342 (2007).","journal-title":"Nat. Biotechnol."},{"key":"81794_CR40","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.smim.2013.04.001","volume":"25","author":"R Pio","year":"2013","unstructured":"Pio, R., Ajona, D. & Lambris, J. D. Complement inhibition in cancer therapy. Semin. Immunol. 25, 54\u201364. https:\/\/doi.org\/10.1016\/j.smim.2013.04.001 (2013).","journal-title":"Semin. Immunol."},{"issue":"Suppl 1","key":"81794_CR41","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1111\/jth.12950","volume":"13","author":"EM Conway","year":"2015","unstructured":"Conway, E. M. Reincarnation of ancient links between coagulation and complement. J. Thromb. Haemost. 13(Suppl 1), S121-132. https:\/\/doi.org\/10.1111\/jth.12950 (2015).","journal-title":"J. Thromb. Haemost."},{"key":"81794_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.blre.2014.09.003","volume":"29","author":"JC Chapin","year":"2015","unstructured":"Chapin, J. C. & Hajjar, K. A. Fibrinolysis and the control of blood coagulation. Blood Rev. 29, 17\u201324. https:\/\/doi.org\/10.1016\/j.blre.2014.09.003 (2015).","journal-title":"Blood Rev."},{"key":"81794_CR43","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/eje-09-0958","volume":"162","author":"M Franchini","year":"2010","unstructured":"Franchini, M., Lippi, G., Manzato, F., Vescovi, P. P. & Targher, G. Hemostatic abnormalities in endocrine and metabolic disorders. Eur. J. Endocrinol. 162, 439\u2013451. https:\/\/doi.org\/10.1530\/eje-09-0958 (2010).","journal-title":"Eur. J. Endocrinol."},{"key":"81794_CR44","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.thromres.2011.11.040","volume":"129","author":"Z Bagoly","year":"2012","unstructured":"Bagoly, Z., Koncz, Z., H\u00e1rsfalvi, J. & Muszbek, L. Factor XIII, clot structure, thrombosis. Thromb. Res. 129, 382\u2013387. https:\/\/doi.org\/10.1016\/j.thromres.2011.11.040 (2012).","journal-title":"Thromb. Res."},{"key":"81794_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1177\/1479164111432788","volume":"9","author":"JM Howes","year":"2012","unstructured":"Howes, J. M. et al. Complement C3 is a novel plasma clot component with anti-fibrinolytic properties. Diabetes Vasc. Dis. Res. 9, 216\u2013225. https:\/\/doi.org\/10.1177\/1479164111432788 (2012).","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"81794_CR46","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","volume":"185","author":"U Amara","year":"2010","unstructured":"Amara, U. et al. Molecular intercommunication between the complement and coagulation systems. J. Immunol. 185, 5628\u20135636. https:\/\/doi.org\/10.4049\/jimmunol.0903678 (2010).","journal-title":"J. Immunol."},{"key":"81794_CR47","doi-asserted-by":"publisher","first-page":"616817","DOI":"10.1155\/2014\/616817","volume":"2014","author":"I P\u0105gowska-Klimek","year":"2014","unstructured":"P\u0105gowska-Klimek, I. & Cedzy\u0144ski, M. Mannan-binding lectin in cardiovascular disease. Biomed. Res. Int. 2014, 616817. https:\/\/doi.org\/10.1155\/2014\/616817 (2014).","journal-title":"Biomed. Res. Int."},{"key":"81794_CR48","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/jth.13208","volume":"14","author":"H Kozarcanin","year":"2016","unstructured":"Kozarcanin, H. et al. The lectin complement pathway serine proteases (MASPs) represent a possible crossroad between the coagulation and complement systems in thromboinflammation. J. Thromb. Haemost. 14, 531\u2013545. https:\/\/doi.org\/10.1111\/jth.13208 (2016).","journal-title":"J. Thromb. Haemost."},{"key":"81794_CR49","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","volume":"28","author":"MM Markiewski","year":"2007","unstructured":"Markiewski, M. M., Nilsson, B., Ekdahl, K. N., Mollnes, T. E. & Lambris, J. D. Complement and coagulation: Strangers or partners in crime?. Trends Immunol. 28, 184\u2013192. https:\/\/doi.org\/10.1016\/j.it.2007.02.006 (2007).","journal-title":"Trends Immunol."},{"key":"81794_CR50","first-page":"333","volume":"3","author":"X Qin","year":"2006","unstructured":"Qin, X. & Gao, B. The complement system in liver diseases. Cell. Mol. Immunol. 3, 333\u2013340 (2006).","journal-title":"Cell. Mol. Immunol."},{"key":"81794_CR51","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1007\/s11095-013-1006-7","volume":"30","author":"AM Thomas","year":"2013","unstructured":"Thomas, A. M. et al. Hepatocyte nuclear factor 4 alpha and farnesoid X receptor co-regulates gene transcription in mouse livers on a genome-wide scale. Pharm. Res.s 30, 2188\u20132198. https:\/\/doi.org\/10.1007\/s11095-013-1006-7 (2013).","journal-title":"Pharm. Res.s"},{"key":"81794_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.biocel.2011.10.001","volume":"44","author":"S Jitrapakdee","year":"2012","unstructured":"Jitrapakdee, S. Transcription factors and coactivators controlling nutrient and hormonal regulation of hepatic gluconeogenesis. Int. J. Biochem. Cell. Biol. 44, 33\u201345. https:\/\/doi.org\/10.1016\/j.biocel.2011.10.001 (2012).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"81794_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s12272-013-0018-5","volume":"36","author":"KJ Oh","year":"2013","unstructured":"Oh, K. J., Han, H. S., Kim, M. J. & Koo, S. H. Transcriptional regulators of hepatic gluconeogenesis. Arch Pharm. Res. 36, 189\u2013200. https:\/\/doi.org\/10.1007\/s12272-013-0018-5 (2013).","journal-title":"Arch Pharm. Res."},{"key":"81794_CR54","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1007\/s00125-011-2301-7","volume":"55","author":"K Hess","year":"2012","unstructured":"Hess, K. et al. A novel mechanism for hypofibrinolysis in diabetes: The role of complement C3. Diabetologia 55, 1103\u20131113. https:\/\/doi.org\/10.1007\/s00125-011-2301-7 (2012).","journal-title":"Diabetologia"},{"key":"81794_CR55","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1210\/jc.2012-2539","volume":"97","author":"MM van Greevenbroek","year":"2012","unstructured":"van Greevenbroek, M. M. et al. Up-regulation of the complement system in subcutaneous adipocytes from nonobese, hypertriglyceridemic subjects is associated with adipocyte insulin resistance. J. Clin. Endocrinol. Metab. 97, 4742\u20134752. https:\/\/doi.org\/10.1210\/jc.2012-2539 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"81794_CR56","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s12026-015-8783-5","volume":"64","author":"SI Vlaicu","year":"2016","unstructured":"Vlaicu, S. I. et al. The role of complement system in adipose tissue-related inflammation. Immunol. Res. 64, 653\u2013664. https:\/\/doi.org\/10.1007\/s12026-015-8783-5 (2016).","journal-title":"Immunol. Res."},{"key":"81794_CR57","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/cei.12574","volume":"180","author":"L Jenny","year":"2015","unstructured":"Jenny, L., Ajjan, R., King, R., Thiel, S. & Schroeder, V. Plasma levels of mannan-binding lectin-associated serine proteases MASP-1 and MASP-2 are elevated in type 1 diabetes and correlate with glycaemic control. Clin. Exp. Immunol. 180, 227\u2013232. https:\/\/doi.org\/10.1111\/cei.12574 (2015).","journal-title":"Clin. Exp. Immunol."},{"key":"81794_CR58","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2337\/db19-0043","volume":"69","author":"SM Tan","year":"2020","unstructured":"Tan, S. M. et al. Complement C5a induces renal injury in diabetic kidney disease by disrupting mitochondrial metabolic agility. Diabetes 69, 83\u201398. https:\/\/doi.org\/10.2337\/db19-0043 (2020).","journal-title":"Diabetes"},{"issue":"Suppl 3","key":"81794_CR59","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.2337\/diab.45.3.s109","volume":"45","author":"T Matsuda","year":"1996","unstructured":"Matsuda, T. et al. Mechanism on disorders of coagulation and fibrinolysis in diabetes. Diabetes 45(Suppl 3), S109-110. https:\/\/doi.org\/10.2337\/diab.45.3.s109 (1996).","journal-title":"Diabetes"},{"key":"81794_CR60","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/s0889-8529(05)70225-5","volume":"30","author":"JA Colwell","year":"2001","unstructured":"Colwell, J. A. Treatment for the procoagulant state in type 2 diabetes. Endocrinol. Metab. Clin. North Am. 30, 1011\u20131030. https:\/\/doi.org\/10.1016\/s0889-8529(05)70225-5 (2001).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"81794_CR61","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1046\/j.1526-0968.2001.00350.x","volume":"5","author":"BR Jaeger","year":"2001","unstructured":"Jaeger, B. R. et al. Consistent lowering of clotting factors for the treatment of acute cardiovascular syndromes and hypercoagulability: A different pathophysiological approach. Ther. Apher. 5, 252\u2013259. https:\/\/doi.org\/10.1046\/j.1526-0968.2001.00350.x (2001).","journal-title":"Ther. Apher."},{"key":"81794_CR62","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.2337\/db08-1666","volume":"58","author":"D Brasacchio","year":"2009","unstructured":"Brasacchio, D. et al. Hyperglycemia induces a dynamic cooperativity of histone methylase and demethylase enzymes associated with gene-activating epigenetic marks that coexist on the lysine tail. Diabetes 58, 1229\u20131236. https:\/\/doi.org\/10.2337\/db08-1666 (2009).","journal-title":"Diabetes"},{"key":"81794_CR63","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1084\/jem.20081188","volume":"205","author":"A El-Osta","year":"2008","unstructured":"El-Osta, A. et al. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 205, 2409\u20132417. https:\/\/doi.org\/10.1084\/jem.20081188 (2008).","journal-title":"J. Exp. Med."},{"key":"81794_CR64","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4161\/epi.1.3.2896","volume":"1","author":"TC Karagiannis","year":"2006","unstructured":"Karagiannis, T. C., Kn, H. & El-Osta, A. The epigenetic modifier, valproic acid, enhances radiation sensitivity. Epigenetics 1, 131\u2013137. https:\/\/doi.org\/10.4161\/epi.1.3.2896 (2006).","journal-title":"Epigenetics"},{"key":"81794_CR65","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4161\/cc.7.4.5405","volume":"7","author":"KN Harikrishnan","year":"2008","unstructured":"Harikrishnan, K. N., Karagiannis, T. C., Chow, M. Z. & El-Osta, A. Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments. Cell Cycle 7, 468\u2013476. https:\/\/doi.org\/10.4161\/cc.7.4.5405 (2008).","journal-title":"Cell Cycle"},{"key":"81794_CR66","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/hmg\/ddn357","volume":"18","author":"J Hauke","year":"2009","unstructured":"Hauke, J. et al. Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition. Hum. Mol. Genet. 18, 304\u2013317. https:\/\/doi.org\/10.1093\/hmg\/ddn357 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"81794_CR67","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.4161\/cc.9.22.13888","volume":"9","author":"R Bayles","year":"2010","unstructured":"Bayles, R., Baker, E., Eikelis, N., El-Osta, A. & Lambert, G. Histone modifications regulate the norepinephrine transporter gene. Cell Cycle 9, 4600\u20134601. https:\/\/doi.org\/10.4161\/cc.9.22.13888 (2010).","journal-title":"Cell Cycle"},{"key":"81794_CR68","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1007\/s00018-011-0727-1","volume":"68","author":"K Ververis","year":"2011","unstructured":"Ververis, K., Rodd, A. L., Tang, M. M., El-Osta, A. & Karagiannis, T. C. Histone deacetylase inhibitors augment doxorubicin-induced DNA damage in cardiomyocytes. Cell. Mol. Life Sci. 68, 4101\u20134114. https:\/\/doi.org\/10.1007\/s00018-011-0727-1 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"81794_CR69","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.4161\/epi.6.12.18396","volume":"6","author":"SG Royce","year":"2011","unstructured":"Royce, S. G. et al. Protective effects of valproic acid against airway hyperresponsiveness and airway remodeling in a mouse model of allergic airways disease. Epigenetics 6, 1463\u20131470. https:\/\/doi.org\/10.4161\/epi.6.12.18396 (2011).","journal-title":"Epigenetics"},{"key":"81794_CR70","doi-asserted-by":"publisher","first-page":"e31573","DOI":"10.1371\/journal.pone.0031573","volume":"7","author":"P Larsson","year":"2012","unstructured":"Larsson, P. et al. Role of histone acetylation in the stimulatory effect of valproic acid on vascular endothelial tissue-type plasminogen activator expression. PLoS ONE 7, e31573. https:\/\/doi.org\/10.1371\/journal.pone.0031573 (2012).","journal-title":"PLoS ONE"},{"key":"81794_CR71","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2174\/1568026617666161104104341","volume":"17","author":"H Rafehi","year":"2017","unstructured":"Rafehi, H., Karagiannis, T. C. & El-Osta, A. Pharmacological histone deacetylation distinguishes transcriptional regulators. Curr. Top. Med. Chem. 17, 1611\u20131622. https:\/\/doi.org\/10.2174\/1568026617666161104104341 (2017).","journal-title":"Curr. Top. Med. Chem."},{"key":"81794_CR72","doi-asserted-by":"publisher","first-page":"27586","DOI":"10.1074\/jbc.M303740200","volume":"278","author":"N Detich","year":"2003","unstructured":"Detich, N., Bovenzi, V. & Szyf, M. Valproate induces replication-independent active DNA demethylation. J. Biol. Chem. 278, 27586\u201327592. https:\/\/doi.org\/10.1074\/jbc.M303740200 (2003).","journal-title":"J. Biol. Chem."},{"key":"81794_CR73","doi-asserted-by":"publisher","first-page":"18236","DOI":"10.1038\/s41598-019-54848-x","volume":"9","author":"MA Rocha","year":"2019","unstructured":"Rocha, M. A. et al. Sodium valproate and 5-aza-2\u2032-deoxycytidine differentially modulate DNA demethylation in G1 phase-arrested and proliferative HeLa cells. Sci. Rep. 9, 18236. https:\/\/doi.org\/10.1038\/s41598-019-54848-x (2019).","journal-title":"Sci. Rep."},{"key":"81794_CR74","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1101\/gr.116095.110","volume":"21","author":"L Pirola","year":"2011","unstructured":"Pirola, L. et al. Genome-wide analysis distinguishes hyperglycemia regulated epigenetic signatures of primary vascular cells. Genome Res. 21, 1601\u20131615. https:\/\/doi.org\/10.1101\/gr.116095.110 (2011).","journal-title":"Genome Res."},{"key":"81794_CR75","first-page":"792","volume":"19","author":"HG Chambers","year":"1999","unstructured":"Chambers, H. G., Weinstein, C. H., Mubarak, S. J., Wenger, D. R. & Silva, P. D. The effect of valproic acid on blood loss in patients with cerebral palsy. J. Pediatr. Orthop. 19, 792\u2013795 (1999).","journal-title":"J. Pediatr. Orthop."},{"key":"81794_CR76","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1067\/mpd.2000.108565","volume":"137","author":"R Gruppo","year":"2000","unstructured":"Gruppo, R. et al. Protein C deficiency related to valproic acid therapy: A possible association with childhood stroke. J. Pediatr. 137, 714\u2013718. https:\/\/doi.org\/10.1067\/mpd.2000.108565 (2000).","journal-title":"J. Pediatr."},{"key":"81794_CR77","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1055\/s-2007-981448","volume":"38","author":"E Cannizzaro","year":"2007","unstructured":"Cannizzaro, E., Albisetti, M., Wohlrab, G. & Schmugge, M. Severe bleeding complications during antiepileptic treatment with valproic acid in children. Neuropediatrics 38, 42\u201345. https:\/\/doi.org\/10.1055\/s-2007-981448 (2007).","journal-title":"Neuropediatrics"},{"key":"81794_CR78","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4103\/0970-9185.125685","volume":"30","author":"C Abdallah","year":"2014","unstructured":"Abdallah, C. Considerations in perioperative assessment of valproic acid coagulopathy. J. Anaesthesiol. Clin. Pharmacol. 30, 7\u20139. https:\/\/doi.org\/10.4103\/0970-9185.125685 (2014).","journal-title":"J. Anaesthesiol. Clin. Pharmacol."},{"key":"81794_CR79","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.nbd.2007.01.015","volume":"26","author":"E Aronica","year":"2007","unstructured":"Aronica, E. et al. Complement activation in experimental and human temporal lobe epilepsy. Neurobiol Dis 26, 497\u2013511. https:\/\/doi.org\/10.1016\/j.nbd.2007.01.015 (2007).","journal-title":"Neurobiol Dis"},{"key":"81794_CR80","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.neuroscience.2007.10.036","volume":"151","author":"E Aronica","year":"2008","unstructured":"Aronica, E. et al. Gene expression profile analysis of epilepsy-associated gangliogliomas. Neuroscience 151, 272\u2013292. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.10.036 (2008).","journal-title":"Neuroscience"},{"key":"81794_CR81","doi-asserted-by":"publisher","first-page":"6452","DOI":"10.1128\/jvi.00422-10","volume":"84","author":"JE Libbey","year":"2010","unstructured":"Libbey, J. E., Kirkman, N. J., Wilcox, K. S., White, H. S. & Fujinami, R. S. Role for complement in the development of seizures following acute viral infection. J. Virol. 84, 6452\u20136460. https:\/\/doi.org\/10.1128\/jvi.00422-10 (2010).","journal-title":"J. Virol."},{"key":"81794_CR82","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.4049\/jimmunol.1203200","volume":"190","author":"D Ricklin","year":"2013","unstructured":"Ricklin, D. & Lambris, J. D. Complement in immune and inflammatory disorders: Therapeutic interventions. J. Immunol. 190, 3839\u20133847. https:\/\/doi.org\/10.4049\/jimmunol.1203200 (2013).","journal-title":"J. Immunol."},{"key":"81794_CR83","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: Ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"81794_CR84","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows\u2013Wheeler transform. Bioinformatics 25, 1754\u20131760. https:\/\/doi.org\/10.1093\/bioinformatics\/btp324 (2009).","journal-title":"Bioinformatics"},{"key":"81794_CR85","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: An efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656 (2014).","journal-title":"Bioinformatics"},{"key":"81794_CR86","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: A Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139\u2013140. https:\/\/doi.org\/10.1093\/bioinformatics\/btp616 (2010).","journal-title":"Bioinformatics"},{"key":"81794_CR87","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"81794_CR88","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon, A. et al. Molecular signatures database (MSigDB) 3.0. Bioinformatics 27, 1739\u20131740. https:\/\/doi.org\/10.1093\/bioinformatics\/btr260 (2011).","journal-title":"Bioinformatics"},{"key":"81794_CR89","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1161\/circulationaha.117.028252","volume":"136","author":"GA Quaife-Ryan","year":"2017","unstructured":"Quaife-Ryan, G. A. et al. Multicellular transcriptional analysis of mammalian heart regeneration. Circulation 136, 1123\u20131139. https:\/\/doi.org\/10.1161\/circulationaha.117.028252 (2017).","journal-title":"Circulation"},{"key":"81794_CR90","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods 25, 402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262 (2001).","journal-title":"Methods"},{"key":"81794_CR91","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/nprot.2007.202","volume":"2","author":"D Shechter","year":"2007","unstructured":"Shechter, D., Dormann, H. L., Allis, C. D. & Hake, S. B. Extraction, purification and analysis of histones. Nat. Protoc. 2, 1445\u20131457. https:\/\/doi.org\/10.1038\/nprot.2007.202 (2007).","journal-title":"Nat. Protoc."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81794-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81794-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81794-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:40:20Z","timestamp":1670035220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-81794-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,25]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["81794"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-81794-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,25]]},"assertion":[{"value":"13 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2163"}}